NYSE : SON
$0.12 (0.22%)
1.45%
78
change: -422 | last: 50027
change: -244 | last: 27124
change: -120 | last: 1446
change: -72 | last: 78421
change: 374 | last: 47-
-
0.00
change: -8.7597 | last: 0.087682.11M
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-04-30 | Vanguard Capital Management | 5.2M | 5.27% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Fuller & Thaler Asset Management, Inc. | 5.9M | 5.98% |
| 2025-10-31 | The Vanguard Group | 9.99M | 10.12% |
| 2022-02-14 | STATE STREET CORPORATION | 7.27M | 7.39% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 10.42M | 10.60% |
| 2022-01-27 | (1) BlackRock, Inc. | 10.63M | 10.80% |
| 2022-01-25 | (1) BlackRock, Inc. | 10.63M | 10.80% |
| 2021-02-11 | Stowers Institute for Medical Research | 5.16M | 5.14% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 10.12M | 10.08% |
| 2021-01-27 | (1) BlackRock, Inc. | 10.12M | 10.10% |
| 2020-02-14 | STATE STREET CORPORATION | 6.89M | 6.88% |
| 2020-02-12 | The Vanguard Group - 23-1945930 | 10.68M | 10.67% |
| 2020-02-04 | (1) BlackRock, Inc. | 11.37M | 11.40% |
| 2019-01-31 | (1) BlackRock, Inc. | 11.33M | 11.40% |
| 2018-01-19 | (1) BlackRock, Inc. | 10.81M | 10.90% |
| 2017-01-17 | (1) BlackRock, Inc. | 10.79M | 10.80% |
| 2016-04-08 | (1) BlackRock, Inc. | 10.65M | 10.50% |
| 2016-01-27 | (1) BlackRock, Inc. | 9.64M | 9.60% |
| 2015-04-10 | (1) BlackRock, Inc. | 10.09M | 10.00% |
| 2015-01-15 | (1) BlackRock, Inc. | 9.25M | 9.10% |
| 2014-02-05 | STATE STREET CORPORATION | 4.77M | 4.70% |
| 2014-01-30 | (1) BlackRock, Inc. | 9.07M | 8.90% |
| 2013-02-12 | STATE STREET CORPORATION | 5.25M | 5.20% |
| 2013-02-01 | (1) BlackRock, Inc. | 8.54M | 8.48% |
| 2011-02-08 | (1) BlackRock, Inc. | 6.93M | 6.73% |
| 2002-02-07 | 04-1867445 | 5.47M | 5.70% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $43.64 | 99.57M | $4.35B | $378.4M | $4.59B | $8.56B |
| 2024-12-31 | $48.85 | 98.64M | $4.82B | $431.01M | $7.3B | $11.69B |
| 2023-12-31 | $55.87 | 98.29M | $5.49B | $138.9M | $3.23B | $8.58B |
| 2022-12-31 | $60.71 | 97.99M | $5.95B | $227.44M | $3.53B | $9.25B |
| 2021-12-31 | $57.89 | 99.61M | $5.77B | $170.98M | $1.84B | $7.44B |
| 2020-12-31 | $59.25 | 100.94M | $5.98B | $564.85M | $2.01B | $7.43B |
| 2019-12-31 | $61.72 | 100.74M | $6.22B | $145.28M | $1.99B | $8.06B |
| 2018-12-31 | $53.13 | 99.83M | $5.3B | $120.39M | $1.39B | $6.57B |
| 2017-12-31 | $53.14 | 100.24M | $5.33B | $254.91M | $1.45B | $6.52B |
| 2016-12-31 | $52.70 | 99.19M | $5.23B | $257.23M | $1.05B | $6.02B |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-29 | $53.18 | 99.7M | $5.3B | $224.48M | $4.95B | $10.03B |
| 2025-12-31 | $43.64 | 99.73M | $4.35B | $378.4M | $4.59B | $8.56B |
| 2025-09-28 | $42.77 | 99.65M | $4.26B | $244.86M | $5.4B | $9.42B |
| 2025-06-29 | $43.56 | 99.45M | $4.33B | $329.8M | $5.69B | $9.69B |
| 2025-03-30 | $47.24 | 98.91M | $4.67B | $181.83M | $7.4B | $11.89B |
| 2024-12-31 | $48.85 | 98.7M | $4.82B | $431.01M | $7.3B | $11.69B |
| 2024-09-29 | $54.63 | 98.26M | $5.37B | $1.93B | $5.07B | $8.51B |
| 2024-06-30 | $50.31 | 98.67M | $4.96B | $140.23M | $3.35B | $8.17B |
| 2024-03-31 | $57.60 | 98.26M | $5.66B | $172.21M | $3.37B | $8.85B |
| 2023-12-31 | $55.87 | 97.96M | $5.47B | $138.9M | $3.23B | $8.56B |
| 2023-10-01 | $53.80 | 98.34M | $5.29B | $257.94M | $3.57B | $8.6B |
| 2023-07-02 | $59.73 | 98.32M | $5.87B | $319.22M | $3.4B | $8.95B |